相关实验视频
Updated: Sep 11, 2025
06:07
Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells
Published on: March 28, 2025
424
对于耗尽的T细胞的高 (I) 成本刺激
Maria N de Menezes1, Ian A Parish1
1Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.
Immunity
|August 13, 2025
概括
诱导性T细胞共刺激剂 (ICOS) 激动剂旨在增强抗癌免疫力. 然而,这项研究发现,CD8+ T细胞上的ICOS表达实际上限制了它们在癌症和慢性感染中的功能.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症免疫疗法癌症免疫疗法
- T细胞生物学T细胞生物学
背景情况:
- 诱导性T细胞共刺激剂 (ICOS) 激动剂正在用于癌症免疫疗法.
- 主流的假设是ICOS激动剂重新激发了耗尽的CD8+T细胞抗癌免疫力.
研究的目的:
- 研究ICOS在CD8+T细胞耗尽和抗癌免疫力中的作用.
主要方法:
- 这项研究利用了慢性病毒感染和瘤模型.
- 研究了CD8+ T细胞内在ICOS表达.
主要成果:
- 意外地发现CD8+ T细胞内在ICOS表达抑制了CD8+ T细胞功能耗尽.
- 这一发现与ICOS激动剂治疗的预期结果形成鲜明对比.
结论:
- 在CD8+ T细胞上的ICOS表达可能会限制它们的抗瘤活性.
- 这挑战了目前使用ICOS激动剂来增强抗癌免疫力的战略.
相关概念视频
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
01:22T Cell Activation and Clonal Selection
4.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
4.6K